{"nct_id":"NCT02242045","title":"Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2014-10-01","start_date_type":"ACTUAL","primary_completion_date":"2014-12-25","primary_completion_date_type":"ACTUAL","completion_date":"2017-10-17","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}